Located in historic Tarrytown, New York, convenient to New York City, Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has preclinical programs in other diseases and disorders. With a strong research base and product focus, Regeneron is able to understand the biology of specific disease states, discover potential therapeutic candidates, and evaluate product candidates in clinical trials. Regeneron has developed several proprietary platform technologies and incorporated these into a comprehensive system to accelerate the discovery and design of fully human antibodies and move these candidates rapidly into clinical development. We offer an extremely competitive compensation and benefits package to all our employees, including stock incentives, 401(k) with company match as well as the expected health and welfare benefits. Comprehensive relocation benefits are available, as required.